Page last updated: 2024-10-26

enoxacin and Infections, Pneumococcal

enoxacin has been researched along with Infections, Pneumococcal in 2 studies

Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.

Research Excerpts

ExcerptRelevanceReference
"Fifteen patients admitted to hospital with acute purulent exacerbations of chronic bronchitis were treated with enoxacin by mouth (three 200 mg capsules twice daily) for ten days."3.67Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study. ( Davies, BI; Maesen, FP; Teengs, JP, 1984)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, BI2
Maesen, FP2
Teengs, JP2
Baur, C1

Other Studies

2 other studies available for enoxacin and Infections, Pneumococcal

ArticleYear
Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14 Suppl C

    Topics: Aged; Bronchitis; Enoxacin; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged

1984
[New oral quinolone compounds in chronic bronchitis].
    Infection, 1986, Volume: 14 Suppl 1

    Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Cipr

1986